BioMarin Pharmaceuticals BMRN Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's earnings yield?
- BioMarin Pharmaceuticals (BMRN) reported earnings yield of 5% in Q3 2025.
- How has BioMarin Pharmaceuticals's earnings yield changed year-over-year?
- BioMarin Pharmaceuticals's earnings yield increased by 107.8% year-over-year, from 2.4% to 5%.
- What is the long-term trend for BioMarin Pharmaceuticals's earnings yield?
- Over 4 years (2020 to 2024), BioMarin Pharmaceuticals's earnings yield has grown at a -10.5% compound annual growth rate (CAGR), from 5.3% to 3.4%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.